1. Home
  2. GTBP vs MITQ Comparison

GTBP vs MITQ Comparison

Compare GTBP & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • MITQ
  • Stock Information
  • Founded
  • GTBP 1965
  • MITQ N/A
  • Country
  • GTBP United States
  • MITQ United States
  • Employees
  • GTBP N/A
  • MITQ N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • GTBP Health Care
  • MITQ Telecommunications
  • Exchange
  • GTBP Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • GTBP 6.6M
  • MITQ 6.0M
  • IPO Year
  • GTBP N/A
  • MITQ 2021
  • Fundamental
  • Price
  • GTBP $2.91
  • MITQ $0.59
  • Analyst Decision
  • GTBP
  • MITQ
  • Analyst Count
  • GTBP 0
  • MITQ 0
  • Target Price
  • GTBP N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • GTBP 28.9K
  • MITQ 67.8K
  • Earning Date
  • GTBP 11-14-2024
  • MITQ 11-14-2024
  • Dividend Yield
  • GTBP N/A
  • MITQ N/A
  • EPS Growth
  • GTBP N/A
  • MITQ N/A
  • EPS
  • GTBP N/A
  • MITQ N/A
  • Revenue
  • GTBP N/A
  • MITQ $18,756,000.00
  • Revenue This Year
  • GTBP N/A
  • MITQ N/A
  • Revenue Next Year
  • GTBP N/A
  • MITQ N/A
  • P/E Ratio
  • GTBP N/A
  • MITQ N/A
  • Revenue Growth
  • GTBP N/A
  • MITQ N/A
  • 52 Week Low
  • GTBP $1.92
  • MITQ $0.42
  • 52 Week High
  • GTBP $10.66
  • MITQ $1.44
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 55.53
  • MITQ 47.73
  • Support Level
  • GTBP $2.94
  • MITQ $0.58
  • Resistance Level
  • GTBP $3.54
  • MITQ $0.67
  • Average True Range (ATR)
  • GTBP 0.27
  • MITQ 0.04
  • MACD
  • GTBP -0.02
  • MITQ -0.00
  • Stochastic Oscillator
  • GTBP 23.05
  • MITQ 13.36

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: